Our bill is the product of consultations with a wide range of stakeholders, as Senator Feinstein has mentioned, and it would give the FDA broader oversight.
Susan Collins: “Our bill is the product of consultations with a wide range of stakeholders, as Senator Feinstein has mentioned, and it…”
On the recordSeptember 21, 2016
Source
congress.govEditor's note · Context
Collins emphasizes stakeholder involvement in creating the bill for FDA oversight.
Share
More from Susan Collins
Oct 9, 2026
I am pleased that these funds are being released to help Mainers afford to heat their homes this winter without having to choose between staying warm and paying for other basic necessities.
Oct 15, 2026
It investigates child trafficking, human trafficking and general child exploitation: drug smuggling, international cartels, financial scams. It recently helped shut down a child pornography ring in the state of Maine. I don't think any of…
Oct 7, 2026
It’s a critical program and the foundation of retirement income for most Mainers, and I’ve voted repeatedly to preserve it.





